1. Home
  2. TENX vs WSBF Comparison

TENX vs WSBF Comparison

Compare TENX & WSBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$15.81

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Logo Waterstone Financial Inc. (MD)

WSBF

Waterstone Financial Inc. (MD)

HOLD

Current Price

$19.40

Market Cap

328.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TENX
WSBF
Founded
1967
1921
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
317.8M
328.4M
IPO Year
2001
2013

Fundamental Metrics

Financial Performance
Metric
TENX
WSBF
Price
$15.81
$19.40
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
1.4M
88.7K
Earning Date
05-15-2026
04-23-2026
Dividend Yield
N/A
3.79%
EPS Growth
N/A
46.53
EPS
N/A
0.34
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$57.24
Revenue Growth
N/A
N/A
52 Week Low
$5.80
$13.08
52 Week High
$19.40
$21.03

Technical Indicators

Market Signals
Indicator
TENX
WSBF
Relative Strength Index (RSI) 56.67 47.71
Support Level $12.84 $19.07
Resistance Level $16.35 $19.76
Average True Range (ATR) 1.27 0.48
MACD -0.15 -0.11
Stochastic Oscillator 41.10 11.86

Price Performance

Historical Comparison
TENX
WSBF

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About WSBF Waterstone Financial Inc. (MD)

Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The majority of its revenue comes from the Community Banking segment.

Share on Social Networks: